Drug Type CAR-NK |
Synonyms- |
Target- |
Action- |
Mechanism Immunologic cytotoxicity, Natural killer cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Carcinoma of ampulla of Vater | Phase 2 | United States | 11 Oct 2023 | |
high grade serous adenocarcinoma of ovary | Phase 2 | United States | 11 Oct 2023 | |
Mesonephroma | Phase 2 | United States | 11 Oct 2023 | |
Pancreatic Ductal Adenocarcinoma | Phase 2 | United States | 11 Oct 2023 | |
Platinum-Resistant Ovarian Carcinoma | Phase 2 | United States | 11 Oct 2023 |